International Journal of COPD,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 2481 - 2495
Published: Nov. 1, 2024
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
progressive
inflammatory
condition
often
complicated
by
cardiovascular
(CVD)
due
to
shared
pathways.
This
review
explores
the
impacts
of
emerging
anti-inflammatory
therapies
in
COPD.
Phosphodiesterase
(PDE)
inhibitors
may
offer
effects
with
improved
lung
function
but
pose
potential
risks
for
arrhythmias
when
PDE3
inhibited
although
PDE4
reduce
events
improving
endothelial
and
reducing
thrombosis.
Similarly,
p38
mitogen-activated
protein
kinase
(MAPK)
phosphoinositide
3-kinase
(PI3K)
target
COPD-related
inflammation
benefit
COPD
patients
CVD.
MAPK
cardiac
fibrosis,
enhance
contractility
lower
risk
arrhythmia.
PI3K
PI3K/Akt
pathway,
which
drives
atherosclerosis
thus
potentially
mitigate
both
plaque
instability
fibrosis.
Biologic
therapies,
including
monoclonal
antibodies
that
inhibit
IL-5,
IL-13/IL-4,
thymic
stromal
lymphopoietin,
IL-33,
IL-17A,
show
promise
exacerbations
require
close
monitoring
their
immunomodulatory
effects.
Single-target
neutrophil
elastase
or
matrix
metalloproteinases
limited
efficacy
aid
stabilizing
atherosclerotic
plaques
through
promoting
vascular
smooth
muscle
cell
proliferation.
However,
tendency
degrade
extracellular
attract
immune
cells
heighten
rupture
risk,
contraindicating
use
Alpha-1
antitrypsin
replacement
therapy
holds
promise,
providing
protection,
especially
myocardial
injury.
Understanding
influence
these
innovative
on
CVD
vital,
making
it
imperative
examine
molecules
at
an
early
stage.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: April 7, 2022
Atopic
dermatitis
(AD)
is
a
chronic
inflammatory
skin
disease
characterized
by
barrier
dysfunction,
dysregulated
immune
response,
and
dysbiosis
with
increased
Staphylococcus
aureus
colonization.
Infiltration
of
various
T
helper
cell
subsets
into
lesional
subsequent
cytokine
release
are
hallmark
AD.
Release
cytokines
both
cells
keratinocytes
plays
key
role
in
inflammation
drives
many
AD
features.
This
review
aims
to
discuss
cytokine-mediated
crosstalk
between
pathogenesis
the
potential
impact
virulence
factors
produced
on
these
interactions.
Mediators of Inflammation,
Journal Year:
2023,
Volume and Issue:
2023, P. 1 - 8
Published: April 15, 2023
Atopic
dermatitis
(AD)
is
a
kind
of
chronic
skin
disease
with
inflammatory
infiltration,
characterized
by
barrier
dysfunction,
immune
response
dysregulation,
and
dysbiosis.
Thymic
stromal
lymphopoietin
(TSLP)
acts
as
regulator
response,
positively
associated
AD
deterioration.
Mainly
secreted
keratinocytes,
TSLP
interacts
multiple
cells
(including
dendritic
cells,
T
mast
cells),
following
induction
Th2-oriented
during
the
pathogenesis
AD.
This
article
primarily
focuses
on
biological
function,
relationship
between
different
cell
populations,
treatments
targeting
TSLP.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(12), P. 6539 - 6539
Published: June 13, 2024
Atopic
dermatitis
(AD)
is
a
chronic
inflammatory
skin
condition
with
high
prevalence
worldwide.
AD
pathogenesis
complex
and
consists
of
immune
system
dysregulation
impaired
barrier,
influenced
by
genetic
environmental
factors.
The
purpose
the
review
to
show
interplay
between
atopic
microbiota.
Human
microbiota
plays
an
important
role
in
course
disease.
Dysbiosis
factor
contributing
development
diseases,
including
dermatitis.
gut
can
influence
composition
microbiota,
strengthening
barrier
regulating
response
via
involvement
bacterial
metabolites,
particularly
short-chain
fatty
acids,
signaling
pathways
gut–skin
axis.
be
modulated
antibiotic
intake,
dietary
adjustments,
hygiene,
living
conditions.
One
promising
strategies
for
modulating
probiotics.
This
offers
summary
how
influences
treatment
AD,
highlighting
aspects
that
warrant
additional
investigation.
Pediatric Allergy and Immunology,
Journal Year:
2022,
Volume and Issue:
33(8)
Published: Aug. 1, 2022
Abstract
Background
Atopic
dermatitis
(AD)
is
a
chronic
inflammatory
skin
disease
affecting
up
to
20%
of
the
pediatric
population
associated
with
alteration
and
gut
microbiome.
Probiotics
have
been
proposed
for
AD
treatment.
The
ProPAD
study
aimed
investigate
therapeutic
effects
probiotic
Lacticaseibacillus
rhamnosus
GG
(LGG)
in
children
AD.
Methods
In
total,
100
patients
aged
6–36
months
were
enrolled
randomized,
double‐blind,
controlled
trial
receive
placebo
(Group
A)
or
LGG
(1
x
10
CFU/daily)
B)
12
weeks.
primary
outcome
was
evaluation
efficacy
supplementation
on
severity
comparing
Scoring
Dermatitis
(SCORAD)
index
at
baseline
(T0)
12‐week
(T12).
A
reduction
≥8.7
points
SCORAD
considered
as
minimum
clinically
important
difference
(MCID).
secondary
outcomes
4‐week
(T16)
after
end
treatment,
number
days
without
rescue
medications,
changes
Infant
Quality
Of
Life
questionnaire
(IDQOL),
microbiome
structure
function,
structure.
Results
rate
subjects
achieving
MCID
T12
T16
higher
Group
B
(
p
<
.05),
remained
.05)The
medications
B.
IDQOL
improved
.05).
beneficial
modulation
observed
only
patients.
Conclusions
could
be
useful
adjunctive
therapy
quality
life
paralleled
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(26), P. 33135 - 33148
Published: June 20, 2024
Atopic
dermatitis
(AD),
a
chronic
skin
condition
characterized
by
itching,
redness,
and
inflammation,
is
closely
associated
with
heightened
levels
of
endogenous
reactive
oxygen
species
(ROS)
in
the
skin.
ROS
can
contribute
to
onset
progression
AD
through
oxidative
stress,
which
leads
release
proinflammatory
cytokines,
T-cell
differentiation,
exacerbation
symptoms.
In
this
study,
we
aim
develop
therapeutic
antioxidant
hydrogel
patch
for
potential
treatment
using
lignin,
biomass
waste
material.
Lignin
contains
polyphenol
groups
that
enable
it
scavenge
exhibit
properties.
The
lignin
patches,
possessing
optimized
mechanical
properties
control
cross-linker
ratio,
demonstrated
high
ROS-scavenging
capabilities.
Furthermore,
excellent
biocompatibility
skin,
exhibiting
beneficial
protecting
human
keratinocytes
under
conditions.
When
applied
an
mouse
model,
effectively
reduced
epidermal
thickness
inflamed
regions,
decreased
mast
cell
infiltration,
regulated
inflammatory
cytokine
levels.
These
findings
collectively
suggest
serves
as
managing
modulating
stress
its
ability.
Frontiers in Cellular Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: Aug. 11, 2022
Background
and
objectives
Multisystem
involvement
in
spinal
muscular
atrophy
(SMA)
is
gaining
prominence
since
different
therapeutic
options
are
emerging,
making
the
way
for
new
SMA
phenotypes
consequent
challenges
clinical
care.
Defective
immune
organs
have
been
found
preclinical
models
of
SMA,
suggesting
an
system
disease.
However,
state
patients
has
not
investigated
so
far.
Here,
we
aimed
to
evaluate
innate
adaptive
immunity
pattern
type
1
3
patients,
before
after
nusinersen
treatment.
Methods
Twenty
one
pediatric
1,
2,
12
adult
2
were
included
this
single-center
retrospective
study.
A
Bio-Plex
Pro-Human
Cytokine
13-plex
Immunoassay
was
used
measure
cytokines
serum
cerebrospinal
fluid
(CSF)
study
cohort
6
months
therapy
with
nusinersen.
Results
We
detected
a
significant
increase
IL-1β,
IL-4,
IL-6,
IL-10,
IFN-γ,
IL-17A,
IL-22,
IL-23,
IL-31,
IL-33,
at
baseline,
compared
reference
ranges
healthy
controls.
Pediatric
showed
also
TNF-α
IL-17F
levels
baseline.
Il-22,
IL-33
decreased
when
decrease
INF-γ,
IL-17A
CSF
both
displayed
detectable
all
no
differences
treatment
Notably,
higher
baseline
expression
IL-23
correlated
worse
motor
function
outcome
patients.
Moreover,
treatment,
presenting
IL-10
concentration
better
Hammersmith
Functional
Motor
Scale
Expanded
(HFMSE)
score.
Discussion
show
inflammatory
signature
that
reduced
upon
SMN2
modulating
presence
mediators
CSF.
Our
findings
enhance
knowledge
potential
implications.
Life,
Journal Year:
2024,
Volume and Issue:
14(3), P. 352 - 352
Published: March 7, 2024
Atopic
dermatitis
(AD)
is
a
persistent
inflammatory
skin
condition
that
impacts
individuals
of
various
age
groups,
including
both
children
and
adults.
Its
pathophysiology
involves
allergens
penetrating
disrupted
epidermal
barrier,
triggering
the
dermal
cells
to
produce
pro-inflammatory
cytokines
eliciting
T-cell-mediated
immune
response.
Notably,
interleukins
(ILs),
particularly
interleukin
4
(IL-4)
13
(IL-13),
play
key
role
in
AD
pathogenesis.
Therapies
directed
at
mechanisms,
Dupilumab,
have
demonstrated
notable
effectiveness
enhancing
lesions,
alleviating
subjective
symptoms,
improving
overall
quality
life
for
with
AD.
Despite
therapeutic
advances,
assessing
severity
remains
challenging.
The
commonly
used
tools,
such
as
SCORAD
DLQI
scores,
rely
on
patient
responses.
Paraclinically,
search
universal
biomarkers
continues,
efforts
identify
reliable
indicators
reflecting
disease
treatment
Various
biomarkers,
Th2-related
chemokines
cytokines,
been
explored,
but
none
gained
recognition
routine
clinical
use.
This
study
aims
investigate
dynamics
plasma
levels
IL-4
IL-13
during
Dupilumab
establish
correlations
between
these
ILs
severity,
measured
using
scores.
ultimate
endpoint
determine
whether
can
serve
their
correlation
patient-reported
feelings
activity
potentially
influencing
inclusion
or
exclusion
diagnostic
elements
practice.
Russian Journal of Clinical Dermatology and Venereology,
Journal Year:
2025,
Volume and Issue:
24(1), P. 7 - 7
Published: Feb. 25, 2025
Patients,
who
suffered
from
atopic
dermatitis
(AD),
are
diagnosed
with
bacterial
and
viral
diseases
significantly
more
often
in
a
severe
form.
Objective.
To
analyze
the
results
of
researches
on
infectious
factors
possibilities
pharmaceutical
impact
patients
AD.
Material
methods.
Search
for
articles
was
carried
out
PubMed,
Scopus,
Google
Scholar,
E-library
scientific
databases
by
following
keywords:
diseases,
dermatitis,
immune
responses.
Results.
Systemic
responses
basis
pathogenic
relationship
between
AD
diseases.
Atopic
march
includes
bronchial
asthma,
allergic
rhinoconjunctivitis
and/or
food
intolerance.
In
adulthood,
may
be
manifested
eczematous
lesions
hands’
skin
contact
dermatitis.
Epithelial
barrier
damage,
increased
concentrations
Th2/Th22
cytokines,
reduced
levels
antimicrobial
peptides,
decreased
diversity,
prevalence
pathogens,
as
well
use
immunosuppressive
agents
therapy
components
pathogenesis
sensibilization
pathology.
Staphylococcus
aureus
is
detected
70—90%
cases
foci
bacteriological
techniques,
whereby
some
have
predominantly
methicillin-resistant
S.
aureus.
A
frequent
presence
human
papilloma
virus,
reduction
microbial
diversity
colonies
Malassezia
fungi
noted.
Patients
higher
visceral
organs
(streptococcal
pharyngitis,
upper
lower
respiratory
tract
infections,
recurrent
otitis,
varicella
disease
urinary
esophagitis
gastritis).
Conclusion.
associated
morbidity
both
most
etiology,
that
should
considered
therapeutic
diagnostic
algorithms.